Cyclic calcipotriene 0.005% foam and 1% 5-fluorouracil cream after cryotherapy in treatment of hyperkeratotic actinic keratosis: A retrospective study - 10/03/21
Funding sources: Supported by an Unrestricted Educational Grant from Mayne Pharma. |
|
Conflicts of interest: Dr Moore has received funds from Almirall (as a consultant, coordinating study investigator, and speaker), Biofrontera (as a consultant and clinical study investigator), Leo (as an advisory board member and speaker), and Mayne Pharma (as a consultant and clinical study investigator). Authors Nguyen and Stephen Moore have no conflicts of interest to declare. |
|
Reprints not available from the authors. |
Vol 84 - N° 4
P. 1148-1150 - avril 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?